Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Neuro-Oncology
Published in: Journal of Neuro-Oncology 1/2018

01-01-2018 | Letter to the Editor

Early initiation of chemoradiation may not influence survival of high-grade gliomas

Authors: Luiz Victor Maia Loureiro, Suzana Maria Fleury Malheiros

Published in: Journal of Neuro-Oncology | Issue 1/2018

Login to get access

Excerpt

To the Editor, …
Literature
1.
2.
Crawford SC, Davis JA, Siddiqui NA, Caestecker L, De Gillis CR, Hole D (2002) The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. Br Med J 325(7357):196CrossRef
3.
Loureiro LV, da Silva Victor E, Callegaro-Filho D, Koch L, de Barros Pontes L, Weltman E et al. (2016) Minimizing the uncertainties regarding the effects of delaying radiotherapy for Glioblastoma: a systematic review and meta-analysis. Radiother Oncol 118:1–8CrossRefPubMed
Metadata
Title
Early initiation of chemoradiation may not influence survival of high-grade gliomas
Authors
Luiz Victor Maia Loureiro
Suzana Maria Fleury Malheiros
Publication date
01-01-2018
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 1/2018
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-017-2633-3

Other articles of this Issue 1/2018

Journal of Neuro-Oncology 1/2018 Go to the issue

Clinical Study

Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02

Laboratory Investigation

A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker

Clinical Study

Long-term outcomes of adult medulloblastoma patients treated with radiotherapy

Letter to the Editor

Hospital volume and group expertise in newly diagnosed glioblastoma management

Laboratory Investigation

Overexpression of COX7A2 is associated with a good prognosis in patients with glioma

Topic Review

Clinical implications of in silico mathematical modeling for glioblastoma: a critical review